Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Radiol ; 45(7): 1016-25, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25620244

ABSTRACT

BACKGROUND: Corpus callosum thickness measurement on mid-sagittal MRI may be a surrogate marker of brain volume. This is important for evaluation of diseases causing brain volume gain or loss, such as HIV-related brain disease and HIV encephalopathy. OBJECTIVE: To determine if thickness of the corpus callosum on mid-sagittal MRI is a surrogate marker of brain volume in children with HIV-related brain disease and in controls without HIV. MATERIALS AND METHODS: A retrospective MRI analysis in children (<5 years old) with HIV-related brain disease and controls used a custom-developed semi-automated tool, which divided the midline corpus callosum and measured its thickness in multiple locations. Brain volume was determined using volumetric analysis. Overall corpus callosum thickness and thickness of segments of the corpus callosum were correlated with overall and segmented (grey and white matter) brain volume. RESULTS: Forty-four children (33 HIV-infected patients and 11 controls) were included. Significant correlations included overall corpus callosum (mean) and total brain volume (P = 0.05); prefrontal corpus callosum maximum with white matter volume (P = 0.02); premotor corpus callosum mean with total brain volume (P = 0.04) and white matter volume (P = 0.02), premotor corpus callosum maximum with white matter volume (P = 0.02) and sensory corpus callosum mean with total brain volume (P = 0.02). CONCLUSION: Corpus callosum thickness correlates with brain volume both in HIV-infected patients and controls.


Subject(s)
Body Weights and Measures/methods , Brain Diseases/complications , Brain Diseases/pathology , Corpus Callosum/pathology , HIV Infections/complications , Magnetic Resonance Imaging , Child, Preschool , Cross-Sectional Studies , Female , Humans , Image Processing, Computer-Assisted , Infant , Male , Organ Size , Pilot Projects , Reproducibility of Results , Retrospective Studies
2.
Childs Nerv Syst ; 30(9): 1549-57, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24853332

ABSTRACT

BACKGROUND: Objective MRI markers of central nervous system disease severity may precede subjective features of HIV encephalopathy in children. Previous work in HIV-infected adults shows that brain atrophy was associated with low CD4 and with neuropsychological impairment. Significant thinning of the corpus callosum (CC), predominantly anteriorly, was also found in HIV-infected adults and correlated with CD4 levels. These findings have not been tested in children. PURPOSE: The aim of this study was to determine if brain volume and midsagittal CC linear measurements (thickness and length) on MRI in children with HIV-related brain disease correlate with clinical and laboratory parameters of disease severity. METHODS: Retrospective MRI analysis in children with HIV-related brain disease used a volumetric analysis software and a semi-automated tool to measure brain volume and callosal thickness/length, respectively. Each measure was correlated with clinical parameters of disease severity including Griffiths Mental Development scores (GMDS), absolute CD4 counts (cells/mm(3)), nadir CD4 (the lowest CD4 recorded, excluding baseline), duration of HAART, and decreased brain growth. RESULTS: Thirty-three children with HIV-related brain disease were included. Premotor segment of the CC mean thickness correlated with age (p = 0.394). Motor CC maximum thickness correlated significantly with general developmental quotient (p = 0.0277); CC length correlated with a diagnosis of acquired microcephaly (p = 0.0071) and to CD4 level closest to date of the MRI scan (p = 0.04). CONCLUSIONS: Length of the CC and the "motor CC segment" may represent surrogate clinical biomarkers of central nervous system disease severity and with decreased level of immunity in HIV-infected patients that precede established HIV encephalopathy.


Subject(s)
AIDS Dementia Complex/pathology , Brain/pathology , CD4 Antigens/metabolism , Corpus Callosum/pathology , Developmental Disabilities/etiology , Statistics as Topic , AIDS Dementia Complex/complications , AIDS Dementia Complex/drug therapy , Antiretroviral Therapy, Highly Active/methods , Brain/growth & development , Brain/virology , Child , Child, Preschool , Corpus Callosum/growth & development , Corpus Callosum/virology , Cross-Sectional Studies , Developmental Disabilities/virology , Female , Follow-Up Studies , Gait Disorders, Neurologic/etiology , Gait Disorders, Neurologic/virology , Humans , Image Processing, Computer-Assisted , Infant , Magnetic Resonance Imaging , Male , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...